Nuveen
PRCT icon

Nuveen’s Procept Biorobotics PRCT Stock Holding History

Nuveen’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.58M Buy
203,027
+5,261
+3% +$132K ﹤0.01% 2149
2026
Q1 		$4.95M Sell
197,766
-84,516
-30% -$2.38M ﹤0.01% 1887
2025
Q4 		$8.88M Sell
282,282
-397,709
-58% -$13.2M ﹤0.01% 1620
2025
Q3 		$24.3M Buy
679,991
+250,141
+58% +$11.4M 0.01% 1027
2025
Q2 		$24.8M Buy
429,850
+235,850
+122% +$13.3M 0.01% 964
2025
Q1 		$11.3M Buy
194,000
+40,198
+26% +$2.74M ﹤0.01% 1484
2024
Q4 		$12.4M Sell
153,802
-94,827
-38% -$8.1M ﹤0.01% 1484
2024
Q3 		$19.9M Buy
248,629
+87,020
+54% +$6.18M 0.01% 1200
2024
Q2 		$9.87M Buy
161,609
+17,696
+12% +$1.05M ﹤0.01% 1582
2024
Q1 		$7.11M Buy
143,913
+2,117
+1% +$101K ﹤0.01% 1795
2023
Q4 		$5.94M Buy
141,796
+40,704
+40% +$1.39M ﹤0.01% 1886
2023
Q3 		$3.32M Buy
101,092
+5,571
+6% +$190K ﹤0.01% 2065
2023
Q2 		$3.38M Buy
95,521
+24,275
+34% +$803K ﹤0.01% 2103
2023
Q1 		$2.02M Sell
71,246
-210,130
-75% -$7.41M ﹤0.01% 2324
2022
Q4 		$11.7M Buy
281,376
+30,464
+12% +$1.31M ﹤0.01% 1387
2022
Q3 		$10.4M Buy
250,912
+75,521
+43% +$3.01M ﹤0.01% 1447
2022
Q2 		$5.73M Buy
175,391
+159,410
+997% +$5.8M ﹤0.01% 1863
2022
Q1 		$559K Buy
15,981
+5,009
+46% +$121K ﹤0.01% 2985
2021
Q4 		$274K Buy
+10,972
New +$406K ﹤0.01% 3191

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nuveen's PRCT Position: Q2 2026 in Review

Nuveen increased its Procept Biorobotics (PRCT) stake by 2.7% in Q2 2026, buying an estimated $132K and bringing the position to 203,027 shares worth $4.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2149.

Nuveen first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $24.8M in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Nuveen held 203,027 shares of Procept Biorobotics worth $4.58M as of Q2 2026.
  • Nuveen bought 5,261 Procept Biorobotics shares in Q2 2026, an estimated $132K.
  • Procept Biorobotics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2149 holding.
  • Nuveen first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • Nuveen's Procept Biorobotics position peaked at $24.8M in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.